TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc. (HURA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · HURA · as of Sep 30, 2025
Ownership Breakdown
68
Institutional Holders
▲ 20 vs Q2
$15.18M
Total Inst. Value
▲ $927,706 vs Q2
63.68M
Shares Outstanding
freeFloat 55.89%
6.12M
13F Shares Held
▼ 270,119 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
HURA largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 2.27M | 5.09% | 5.09% | $5.63B | Nov 7, 2025 | ▲ 35.4K |
BLACKROCK, INC. pharmaceutical preparations | 1.52M | 3.42% | 3.42% | $3.77B | Nov 12, 2025 | ▲ 183.7K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 622.8K | 1.40% | 1.40% | $1.54B | Nov 12, 2025 | ▲ 39.8K |
STATE STREET CORP pharmaceutical preparations | 275.5K | 61.84% | 61.84% | $683.34M | Nov 14, 2025 | ▲ 47.2K |
BANK OF NEW YORK MELLON CORP pharmaceutical preparations | 197.3K | 44.28% | 44.28% | $489.32M | Nov 3, 2025 | ▼ 54.8K |
NORTHERN TRUST CORP pharmaceutical preparations | 186.8K | 41.93% | 41.93% | $463.30M | Nov 14, 2025 | ▼ 14.4K |
UBS GROUP AG pharmaceutical preparations | 141.5K | 31.75% | 31.75% | $350.86M | Nov 13, 2025 | ▼ 114.5K |
APOLLON WEALTH MANAGEMENT, LLC pharmaceutical preparations | 133.5K | 29.97% | 29.97% | $331.14M | Oct 17, 2025 | ▲ 18.3K |
SUNCOAST EQUITY MANAGEMENT pharmaceutical preparations | 104.4K | 23.43% | 23.43% | $258.93M | Oct 21, 2025 | — held |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC pharmaceutical preparations | 79.0K | 17.74% | 17.74% | $196.00M | Nov 10, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
12
Increased
+355.2K shares12
New Positions
first time holders12
Decreased
−242.4K shares0
Sold Out
fully exitedNet shares change (top 50)
+112.8K
+355.2K / −242.4K
Net new holders
+12
12 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
HURA insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Bianco James A. Chief Executive Officer | May 28, 2026 | Gift | 150,000 | — | — | 2.17M | Form 4 ↗ |
Tendler Craig director | Feb 12, 2026 | Award | 156,240 | $1.29 | $201.5K | 156.2K | Form 4 ↗ |
Ng George K director | Feb 12, 2026 | Award | 156,240 | $1.29 | $201.5K | 156.2K | Form 4 ↗ |
MANUSO JAMES S J director | Feb 12, 2026 | Award | 156,240 | $1.29 | $201.5K | 156.2K | Form 4 ↗ |
List Alan director | Feb 12, 2026 | Award | 156,240 | $1.29 | $201.5K | 156.2K | Form 4 ↗ |
Hoffman Robert E. director | Feb 12, 2026 | Award | 156,240 | $1.29 | $201.5K | 156.2K | Form 4 ↗ |
Dearborn Dan Chief Financial Officer | Jan 6, 2026 | Award | 273,696 | $0.73 | $199.8K | 273.7K | Form 4 ↗ |
Bianco James A. Chief Executive Officer | Jan 6, 2026 | Award | 610,332 | $0.73 | $445.5K | 610.3K | Form 4 ↗ |
Dearborn Dan Chief Financial Officer | Dec 12, 2025 | Award | 1,531,367 | $1.02 | $1.56M | 1.53M | Form 4 ↗ |
Bianco James A. Chief Executive Officer | Dec 12, 2025 | Award | 3,414,891 | $1.02 | $3.48M | 3.41M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
TuHURA Biosciences, Inc. (HURA) is primarily owned by institutional investors, who hold approximately 9.6% of total shares outstanding. Company insiders own approximately 44.11%, while retail and public investors account for the remaining 46.28%.
The largest institutional shareholder of TuHURA Biosciences, Inc. is VANGUARD GROUP INC, holding approximately 2.27 million shares — equal to 5.09% of outstanding shares — as of September 30, 2025.
A total of 68 institutional investors currently hold HURA stock, with a combined institutional value of approximately $15,176,696 as of the most recent 13F filing period.
Frequently asked questions
HURA ownershipTuHURA Biosciences, Inc. (HURA) is primarily owned by institutional investors, who hold approximately 9.6% of shares. The largest shareholder is VANGUARD GROUP INC with a 5.09% stake. Company insiders hold 44.11%. Data sourced from SEC Form 13F as of September 30, 2025.